Terrana Biosciences
A generative RNA platform for agriculture, designing heritable traits and crop protection solutions for comprehensive plant health.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $50.0m | Early VC | |
| Total Funding | 000k | ||
Related Content
Terrana is developing a novel category of RNA-based solutions for the agricultural sector. The company operates a comprehensive platform that combines RNA technology with generative artificial intelligence to design and create products that address multiple aspects of plant health. This approach aims to overcome the limitations of traditional methods like seed genetics or chemical crop protection.
The core of its business model is the creation of versatile RNA-based solutions applicable throughout a plant's lifecycle, from seed treatment to post-harvest. A key feature is the ability to enable heritable crop traits, which can be passed down through generations of plants, starting with applications in crop protection. This suggests a business model that could involve licensing technology, selling treated seeds, or offering direct-to-farm solutions.
Terrana targets the broad agriculture market, offering solutions that can impact seeds, traits, and overall crop resilience. The company is part of the Flagship Pioneering ecosystem, indicating strong backing and a foundation in life sciences research.
Keywords: RNA technology, generative AI, agriculture, crop protection, plant health, heritable traits, seed genetics, biotechnology, agritech, life sciences